Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday. Shares of Progress Software Corp (NASDAQ: PRGS ) fell sharply in pre-market trading after the company reported third-quarter financial results. Progress Software reported fiscal third-quarter revenue of $246 million, down 2% year over year, while non-GAAP EPS rose 13% to $1.69 and ARR increased 1% to $873 million. Progress Software shares dipped 2.3% to $39.05 in pre-market trading. Here are some other stocks moving lower in pre-market trading. Corteva Inc (NYSE: CTVA ) tumbled 56.6% to $33.89 in pre-market trading. Nft Ltd (NYSE: MI ) fell 54.6% to $0.98 in pre-market trading after the company announced a $36 million offering of 80 million shares at $0.45 per share. Vivakor inc (NASDAQ: VIVK ) fell 20.8% to $0.40 in pre-market trading after the company announced a 1-for-15 reverse stock split of its issued and outstanding common stock. Lion Group Holding Ltd — ADR (NASDAQ: LGHL ) fell 15.4% to $4.81 in pre-market trading after jumping over 25% on Wednesday. Lion Group recently announced a strategic reallocation of a portion of its digital-asset treasury. Inventiva SA — ADR (NASD
S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday. Shares of Progress Software Corp (NASDAQ: PRGS ) fell sharply in pre-market trading after the company reported third-quarter financial results. 69 and ARR increased 1% to $873 million.
05 in pre-market trading. Here are some other stocks moving lower in pre-market trading. 89 in pre-market trading. 45 per share.
40 in pre-market trading after the company announced a 1-for-15 reverse stock split of its issued and outstanding common stock. 81 in pre-market trading after jumping over 25% on Wednesday. Lion Group recently announced a strategic reallocation of a portion of its digital-asset treasury. 39 in pre-market trading after gaining 12% on Wednesday.
63 in pre-market trading. 96 in pre-market trading. 81 in pre-market trading. 99 in pre-market trading.
On Wednesday, a federal court in Delaware ruled that two claims of a patent asserted by United Therapeutics (NASDAQ: UTHR ) are valid and infringed by Liquidia, the company said in a press release. The litigation concerns Yutrepia (treprostinil) inhalation powder, Liquidia’s lead product. 29 in pre-market trading. Photo via Shutterstock